ACP guidance on PSA tests differs slightly from AAFP recommendations

04/24/2013 | AAFP News Now

New prostate cancer screening recommendations from the American College of Physicians differ slightly from those issued by the AAFP and the U.S. Preventive Services Task Force. The ACP calls for physicians to discuss the limited benefits and substantial harms of testing with patients ages 50 to 69 and perform screening only if a patient clearly asks for it, while the AAFP recommends against PSA screening in asymptomatic men of any age. USPSTF member Mark Ebell, M.D., said more research into PSA testing will help resolve uncertainty.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA